February 2016 Briefing - Pathology
Physician's Briefing,
Here are what the editors at HealthDay consider to be the most important developments in Pathology for February 2016.
Here are what the editors at HealthDay consider to be the most important developments in Pathology for February 2016.
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for February 2016.
FRIDAY, Feb. 12, 2016 (HealthDay News) -- Only one-in-five patients with heart failure with reduced ejection fraction (HFrEF…
Share this article: Only 1 in 5 HFrEF patients get digoxin at discharge (HealthDay News) — Only one-in-five patients with heart…